Innovator Intercepts at HLTH 2023

In this episode of the Verizon Healthcare podcast, host Robin Goldsmith introduces the Health 2023 Conference in Las Vegas, themed around “creating a better future for all.” The podcast features conversations with experts, friends, and partners in the healthcare industry. They delve into the exciting trends shaping the future of healthcare, with a specific focus on the role of artificial intelligence (AI). AI is recognized as a significant driver of healthcare analytics, aiding in assessment and remote monitoring, potentially reducing the need for in-person medical visits.

The experts stress the importance of collaboration among healthcare companies and the adoption of scalable solutions. They also highlight the value of robust AI strategies. The discussion further explores the evolving role of AI in healthcare and its potential to elevate the standard of care. This podcast episode offers a snapshot of the Health 2023 Conference, shedding light on the innovative trends shaping the healthcare landscape.

Recent Episodes

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…